Why the study?
Elevated blood pressure and proteinuria are established risk factors for pediatric CKD progression, but the role of detailed ambulatory blood pressure monitoring parameters required further evaluation.
Is reduced systolic blood pressure dipping a risk factor for eGFR decline in children with CKD II-V?
Is reduced systolic blood pressure dipping a risk factor for eGFR decline in children with CKD II-V?
Reduced systolic blood pressure dipping is an independent predictor of eGFR decline in children with chronic kidney disease.
Supports ambulatory BP monitoring in pediatric CKD; hypothesis-generating for dipping as modifiable factor in eGFR decline.
Background: Elevated blood pressure and proteinuria are well-established risk factors for chronic kidney disease (CKD) progression in children. This study aimed to analyze risk factors for CKD progress, emphasizing detailed ambulatory blood pressure (ABPM) data. Methods: In 55 children with CKD II−V, observed for ≥1 year or until initiation of kidney replacement therapy, we analyzed ABPM, clinical, and biochemical parameters. Results: At the beginning, the glomerular filtration rate (eGFR) was 66 (interquartile range—IQR: 42.8−75.3) mL/min/1.73 m2, and the observation period was 27 (16−36) months. The mean eGFR decline was 2.9 ± 5.7 mL/min/1.73 m2/year. eGFR decline correlated (p < 0.05) with age (r = 0.30), initial proteinuria (r = 0.31), nighttime systolic and mean blood pressure (r = 0.27, r = 0.29), and systolic and diastolic blood pressure dipping (r = −0.37, r = −0.29). There was no relation between mean arterial pressure during 24 h (MAP 24 h Z-score) and eGFR decline and no difference in eGFR decline between those with MAP 24 h < and ≥50 th percentile. In multivariate analysis, systolic blood pressure dipping (beta = −0.43), presence of proteinuria (beta = −0.35), and age (beta = 0.25) were predictors of eGFR decline. Conclusions: Systolic blood pressure dipping may be a valuable indicator of CKD progression in children.
No takes yet. Share an insight, caveat, or question.
Deja et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: